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Abstract Improved health may extend or shorten the
duration of cognitive impairment by postponing incidence
or death. We assess the duration of cognitive impairment in
the US Health and Retirement Study (1992–2004) by self
reported BMI, smoking and levels of education in men and
women and three ethnic groups. We deﬁne multistate life
tables by the transition rates to cognitive impairment,
recovery and death and estimate Cox proportional hazard
ratios for the studied determinants. 95% conﬁdence inter-
vals are obtained by bootstrapping. 55 year old white men
and women expect to live 25.4 and 30.0 years, of which 1.7
[95% conﬁdence intervals 1.5; 1.9] years and 2.7 [2.4; 2.9]
years with cognitive impairment. Both black men and
women live 3.7 [2.9; 4.5] years longer with cognitive
impairment than whites, Hispanic men and women 3.2 [1.9;
4.6] and 5.8 [4.2; 7.5] years. BMI makes no difference.
Smoking decreases the duration of cognitive impairment
with 0.8 [0.4; 1.3] years by high mortality. Highly educated
men and women live longer, but 1.6 years [1.1; 2.2] and
1.9 years [1.6; 2.6] shorter with cognitive impairment than
lowly educated men and women. The effect of education is
more pronounced among ethnic minorities. Higher life
expectancy goes together with a longer period of cognitive
impairment, but not for higher levels of education: that
extends life in good cognitive health but shortens the period
of cognitive impairment. The increased duration of cogni-
tive impairment in minority ethnic groups needs further
study, also in Europe.
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Introduction
Cognitive impairment is a major cause of dementia and
associated disability and care dependence in aging socie-
ties. The age speciﬁc prevalence of dementia doubles with
every 5 years of age, from approximately 1.5% in persons
aged 60–69 to 40% among nonagenarians [1, 2]. In the
absence of effective interventions, numbers of people with
dementia will increase as a simple consequence of an
increase in the size of the elderly population [3]. This
implies large increases of long term care needs. We used
multistate life tables (MSLT) to identify duration of cog-
nitive impairment in the synthetic (imaginary) cohort of a
life table (see Fig. 1). MSLT is an important demographic
tool to document life course processes, here the process to
cognitive impairment and death [4]. Contrary to the classic
(Sullivan) healthy life table [5], which combines preva-
lence with event rates, the MSLT is internally consistent by
building exclusively on event rates [6]. The results of
MSLT are highly intuitive by translating age speciﬁc event
rates in measures of duration in the life table: how long
individuals at a certain age will live in a speciﬁed good and
bad health condition. Conditioned by risk status, the results
assist both individuals and policy makers in health
planning.
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as causes of dementia. In European population, incidence
rates of dementia among women are higher, often attrib-
uted to mortality selection among men [7]. Current evi-
dence supports an important role for vascular risk factors in
the clinical manifestation of cognitive decline [2, 8–10].
Blood pressure is correlated to dementia, but the relation
depends on the life course [11, 12]. Obesity shows the
same life course dependency. A higher BMI in mid life has
been related to an increased risk of dementia, mediated by
vascular risk. But later in life, an accelerated decline of
BMI predicts Alzheimer’s disease [13]. Elderly smokers
have increased risks of dementia and cognitive decline
[14], but the role of smoking in shortening the life span is
indisputable—which might shorten the life span with
cognitive impairment at the end of life.
There is sufﬁcient evidence that psychosocial factors
such as educational attainment, social networking and
mentally stimulating activities protect against dementia [2].
Last but not least, there is a clear association of incidence
and duration of dementia with minority ethnic groups,
observed in several countries and several ethnic minorities
[15–19]. The reasons why minority ethnic groups suffer
more and longer from dementia are ill understood but
certainly manifold, partly linked to lower education and
social deprivation [20].
The aim of this paper is to support future epidemio-
logic-demographic predictions of disability by assessing
the duration of cognitive impairment and the effect of
risk factors on this duration. We used data from the
publicly available HRS study, a model for the European
SHARE study (http://www.share-project.org/). The HRS
had then seven rounds of interviews, SHARE but the ﬁrst
round. In the HRS study, cognitive impairment was
deﬁned by the Telephone Interview Cognitive Screen
(TICS) or proxy-interviews [21].. We used MSLT to
assess the duration of cognitive impairment, dependent on
age, sex, ethnic status and the risk factors BMI, smoking
and education.
Methods
Data and study population
We used the RAND version F of the Health and Retirement
Study (HRS) data ﬁle containing the HRS and the Asset
and Health Dynamics Among the Oldest Old (AHEAD)
which began in 1992 and 1993, respectively, and were
merged in 1998. The Children of the Depression cohort and
War Baby cohort were included. We will refer to the total
survey as HRS. The HRS survey includes a nationally
representative sample of initially non-institutionalized
individuals, and spouses, who were re-interviewed bian-
nually, with oversampling of minority ethnic groups. We
used data from 7 waves from 1992 to 2004. Response was
on average 86%. Data on vital status and month and year of
death are obtained through the mortality register (the
National Death Index) and exit interviews.
Cognitive impairment in the AHEAD93 and HRS98 was
measured by a modiﬁed version of the TICS (The Tele-
phone Interview Cognitive Screen) instrument, a telephone
interview adapted from the MMSE (mini mental state
examination) [21, 22]. There were six tasks yielding a
maximum of 35 points, with higher scores implying better
functioning. A description of the TICS supporting the
deﬁnition of cognitive impairment can be found elsewhere
[23–25]. In short, 8 points or less identiﬁes the population
with severe cognitive impairment. We explored the sensi-
tivity of cut off points 7 and 9, which did not result in
meaningful changes (results not shown). In about 10% of
the sample in each wave, proxies represented respondents.
Respondents whose memory and judgment were assessed
as poor, were classiﬁed as cognitively impaired. We
deﬁned recovery as scoring 10 points or more, having been
previously identiﬁed as cognitively impaired.
As behavioural risk factors, we studied self reported
body mass index (BMI), smoking and levels of education.
We categorized differences by ethnicity as non-Hispanic
white (further called white), non-Hispanic black (further
called black) and Hispanic. Self-reported weight and height
at the ﬁrst report deﬁnes BMI (kg/m2), classiﬁed as low
normal weight (18.5–22.9), high normal weight (23–24.9),
overweight (25–29.9), mildly obese (30–34.9) and severely
obese (35?). To avoid weight loss as a sign of impending
disease, we excluded persons with a BMI less than 18.5.
Smoking status is included as ‘never smoked’, ‘stopped
smoking’ and ‘currently smoking’ based on the ﬁrst
reported information on smoking status. We distinguish
three groups of educational attainment: Less than high-
school or General Educational Development (GED), High-
School graduate and some college, and College graduate
and above.
Free of 
impairment
Death
With 
Impairment
Incidence
Recovery
Mortality,
unimpaired
Mortality,
impaired
Fig. 1 Structure of a multi state life table model with two health
states. The transitions are age dependent and conditioned by risk
status
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123We used a multistate model for the analysis of transition
rates to cognitive impairment, recovery and death (see
Fig. 1). Lacking exact event dates of incidence and
recovery, we assume these transitions to occur halfway
between two biannual waves. An alternative assumption
would be to assume a continuous-time Markov process,
implying an exponential distribution of time of transition
within the interval, but in intervals of 2 years, the differ-
ence between both assumptions is small [26]. Two separate
statistical analyses were conducted: Cox proportional
hazard analyses and multistate life table analyses. We
estimated Cox proportional hazard models, including
sampling weights to account for the oversampling of
minority ethnic groups and used age as the time scale for
the baseline hazard, consistent with the life table structure
[27]. We used Schoenfeld residuals test to verify propor-
tionality of the hazard model over age. Because the effect
of the risk factors was not proportional for the transitions
healthy to death or cognitive impairment, we ran the Cox
analysis separately for ages 55–75 under and age 75?.
These analyses result in proportional hazard ratios for each
risk factor of interest with respect to a reference category.
For the multistate life table analyses, we estimated baseline
age-speciﬁc hazard rates of transitions to death and cog-
nitive impairment for males, females and for each deter-
minant separately. Rates estimated by years of age exhibit
considerable random variation. The rates are therefore
smoothed by ﬁtting an exponential (Poisson) model
through the age-speciﬁc rates. The exponential function
ﬁtted well. The multistate life table applies the estimated
rates to a synthetic cohort and summarizes the age-speciﬁc
transition rates into durations, here life expectancy at age
55 with or without cognitive impairment. Life expectancies
by risk factor are only shown for the white population, as
the sample of individuals of ethnic minorities by risk factor
was too small. Conﬁdence intervals for the multistate life
table outcomes were calculated using bootstrapping with
250 replicates. The bootstrap procedure comprised both the
estimation of the rates and the computation of the ensuing
life expectancies.
Results
From the HRS sample (N = 30,207), we selected indi-
viduals who participated at least 2 waves (N = 24,586),
reported information on BMI, smoking and education
(23,817), and had a BMI[18.5 (23,408) and were aged 55
or over, resulting in a sample of 22,388, 9,834 males and
12,554 females.
Table 1 shows the characteristics of the study popula-
tion. 861 men and 1,332 women experienced the onset of
cognitive impairment during observation, of which 39%
and 35% reported by proxy. A total of 557 individuals
experienced recovery, 28% and 23% for males and females
respectively. We ignored recovery in multiple relapse/
recovery/relapse episodes as these were rare (N = 26).
Table 2 shows the proportional hazard ratios for tran-
sitions to death and to cognitive impairment by race, BMI,
smoking status and levels of education. The effects of risk
factors on recovery from cognitive impairment to healthy
were small (results not shown). The risk to cognitive
impairment is about twice as high for blacks and Hispanics
as for whites (not signiﬁcant for Hispanics aged 75?). BMI
has little effect on the incidence of cognitive impairment or
on the survival of the impaired. BMI over 35 increases the
risk of cognitive impairment for males. This effect disap-
pears when we control for interaction effects with race,
smoking and education. The evidence of an effect of
smoking is mixed and disappears after including interac-
tion effects (results not shown). Higher education delays
incidence of cognitive decline in both males and females.
Table 1 Distribution of sample characteristics at entry into the
survey
Males Females
Total number of individuals 9,834 100% 12,554 100%
Total personyears 78,180 98,674
Incidence of cognitive impairment 861 1,332
Mortality (all causes) 2,446 2,409
Race/ethnicity
White 7,763 79% 9,579 76%
Black 1,309 13% 1,985 16%
Hispanic 762 8% 990 8%
Education
Low education 3,409 35% 4,258 34%
Medium education 4,446 45% 6,682 53%
High education 1,979 20% 1,614 13%
Smoking
Never smoked 2,568 26% 6,592 53%
Stopped smoking 5,036 51% 3,731 30%
Currently smoking 2,230 23% 2,231 18%
BMI
BMI 18.5–23 1,287 13% 3,075 24%
BMI 23–25 1,800 18% 2,189 17%
BMI 25–30 4,804 49% 4,357 35%
BMI 30–35 1,516 15% 1,975 16%
BMI 35? 427 4% 958 8%
Age at entry
[55,65] 6,045 61% 7,013 56%
[65,75] 2,424 25% 3,206 26%
[75,85] 1,143 12% 1,849 15%
[85,95] 216 2% 459 4%
[95,105] 6 0% 27 0%
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123Table 2 Cox proportional hazard ratios by risk factor status (95% conﬁdence intervals), adjusted for each other
Males Females
55–74 75? 55–74 75?
Healthy to death
White 1.00 1.00 1.00 1.00
Black 1.30 (1.09; 1.55) 1.16 (0.93; 1.44) 1.35 (1.10; 1.65) 1.23 (1.00; 1.52)
Hispanic 0.77 (0.53; 1.11) 0.90 (0.59; 1.38) 0.99 (0.66; 1.48) 1.03 (0.63; 1.66)
BMI 18.5–22.9 1.39 (1.16; 1.67) 1.27 (1.07; 1.51) 0.83 (0.67; 1.02) 1.04 (0.88; 1.22)
BMI 23–24.9 1.00 1.00 1.00 1.00
BMI 25–29.9 0.89 (0.76; 1.03) 0.87 (0.75; 1.01) 0.90 (0.75; 1.09) 0.91 (0.77; 1.07)
BMI 30–34.9 1.14 (0.95; 1.37) 1.01 (0.81; 1.25) 0.98 (0.77; 1.23) 0.93 (0.76; 1.15)
BMI 35? 1.45 (1.09; 1.91) 1.23 (0.83; 1.83) 1.55 (1.21; 1.99) 1.22 (0.89; 1.66)
Never smoked 1.00 1.00 1.00 1.00
Stopped smoking 1.42 (1.21; 1.66) 1.25 (1.08; 1.44) 1.37 (1.17; 1.60) 1.21 (1.06; 1.37)
Currently smoking 2.67 (2.25; 3.17) 1.67 (1.37; 2.03) 2.57 (2.18; 3.03) 1.85 (1.52; 2.24)
Low education 1.00 1.00 1.00 1.00
Medium education 0.93 (0.82; 1.05) 0.91 (0.80; 1.03) 0.70 (0.61; 0.81) 0.83 (0.74; 0.94)
High education 0.62 (0.52; 0.73) 0.65 (0.54; 0.78) 0.47 (0.36; 0.61) 0.85 (0.69; 1.04)
Healthy to CI
White 1.00 1.00 1.00 1.00
Black 2.96 (2.27; 3.86) 1.83 (1.23; 2.71) 2.92 (2.22; 3.84) 2.06 (1.55; 2.72)
Hispanic 1.85 (1.09; 3.12) 1.76 (0.88; 3.50) 2.11 (1.32; 3.36) 1.50 (0.75; 2.99)
BMI 18.5–22.9 1.63 (1.07; 2.51) 1.00 (0.70; 1.44) 1.13 (0.72; 1.77) 1.11 (0.84; 1.47)
BMI 23–24.9 1.00 1.00 1.00 1.00
BMI 25–29.9 1.10 (0.77; 1.58) 0.70 (0.51; 0.95) 1.34 (0.90; 1.99) 0.93 (0.71; 1.23)
BMI 30–34.9 1.27 (0.84; 1.92) 0.65 (0.40; 1.07) 1.36 (0.88; 2.10) 0.89 (0.63; 1.26)
BMI 35? 1.71 (1.00; 2.92) 0.66 (0.24; 1.82) 1.41 (0.87; 2.28) 0.89 (0.50; 1.58)
Never smoked 1.00 1.00 1.00 1.00
Stopped smoking 0.69 (0.52; 0.92) 1.02 (0.76; 1.37) 1.45 (1.10; 1.90) 0.86 (0.69; 1.07)
Currently smoking 0.93 (0.69; 1.26) 0.88 (0.55; 1.39) 1.26 (0.93; 1.70) 0.63 (0.39; 1.01)
Low education 1.00 1.00 1.00 1.00
Medium education 0.50 (0.39; 0.64) 0.53 (0.40; 0.70) 0.36 (0.28; 0.46) 0.65 (0.53; 0.79)
High education 0.14 (0.09; 0.24) 0.42 (0.28; 0.63) 0.25 (0.15; 0.40) 0.49 (0.33; 0.73)
CI to death
White 1.00 1.00 1.00 1.00
Black 0.72 (0.37; 1.40) 0.74 (0.49; 1.12) 1.37 (0.73; 2.57) 0.80 (0.55; 1.15)
Hispanic 0.90 (0.32; 2.56) 0.42 (0.16; 1.14) 0.91 (0.22; 3.72) 0.76 (0.35; 1.65)
BMI 18.5–22.9 1.56 (0.66; 3.67) 0.99 (0.65; 1.52) 0.97 (0.42; 2.21) 1.25 (0.86; 1.81)
BMI 23–24.9 1.00 1.00 1.00 1.00
BMI 25–29.9 0.82 (0.36; 1.83) 0.79 (0.53; 1.17) 0.62 (0.27; 1.41) 0.95 (0.63; 1.43)
BMI 30–34.9 1.89 (0.71; 5.01) 0.94 (0.50; 1.79) 0.60 (0.24; 1.51) 1.24 (0.76; 2.01)
BMI 35? 3.33 (1.22; 9.07) 1.26 (0.50; 3.17) 0.48 (0.14; 1.60) 1.60 (0.73; 3.51)
Never smoked 1.00 1.00 1.00 1.00
Stopped smoking 1.23 (0.60; 2.53) 1.06 (0.74; 1.53) 1.14 (0.59; 2.19) 1.16 (0.84; 1.60)
Currently smoking 2.04 (1.01; 4.10) 1.28 (0.76; 2.17) 1.10 (0.55; 2.18) 1.38 (0.76; 2.51)
Low education 1.00 1.00 1.00 1.00
Medium education 1.17 (0.62; 2.21) 1.22 (0.85; 1.75) 3.36 (1.83; 6.17) 1.44 (1.08; 1.92)
High education 2.08 (0.84; 5.17) 1.29 (0.68; 2.43) 1.33 (0.40; 4.45) 1.40 (0.77; 2.56)
Signiﬁcant ratios are printed in bold
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123The mortality risks of higher educated individuals, once
cognitively impaired, tend to be higher compared to the
lower educated, although this is only signiﬁcant for med-
ium educated females. Higher education protects more
against cognitive impairment between age 55 and 75 than
at 75 and over, the effect of education is stronger for blacks
than for whites: hazard ratios to cognitive impairment for
black men and women are 0.09 [95% conﬁdence intervals
0.01; 1.48] and 0.10 [0.01; 0.73] compared to 0.28 [0.16;
0.48] and 0.25 [0.11; 0.58] for whites.
Translating age, sex and risk factor-speciﬁc transition
rates into life expectancies at age 55 deﬁnes the stratiﬁed
life expectancy with and without cognitive impairment for
each risk group. The life expectancy of our study popula-
tion was respectively 25.4 and 30.0 years for whites, 22.9
and 26.5 for blacks and 27.0 and 31.9 for Hispanics (see
Table 3). Average lifespan with cognitive impairment
differs remarkably between the ethnic groups. In the white
population, 55 year old males and females spent respec-
tively 1.7 [1.5; 1.9] years and 2.7 [2.4; 2.9] years with
cognitive impairment. Although their life expectancy was
shorter, male and female blacks lived on average 3.7 [2.9;
4.5] years longer with cognitive impairment than whites
(see Table 2 and Fig. 2). Blacks lived more than 5 year
shorter free of cognitive impairment. Hispanic men and
women lived 3.2 [1.9; 4.6] and 5.8 [4.2; 7.5] years more
with cognitive impairment compared to white men and
women. Hispanics lived longer than whites, but shorter free
of cognitive impairment.
The number of years lived with cognitive impairment
varied among risk factors (see Table 4 and Fig. 2). Data
are only shown for the white population in Table 4. BMI
does not change duration of life with cognitive impairment.
Smoking shortens the duration of cognitive impairment.
Ever and current smokers live signiﬁcantly shorter than
never smokers with cognitive impairment: -0.7 years
[-1.2; -0.3] for men and -0.9 [-1.3; -0.5] for women.
The high mortality of smoking compresses both morbidity
and a healthy life [28–30]. A high education effectively
and seriously compresses cognitive impairment. Highly
educated men live 1.1 years [0.7; 1.4] with cognitive
impairment, which is 1.6 years [1.1; 2.2] shorter than lowly
educated men. Highly educated women, live 1.9 years [1.4;
2.4] with cognitive impairment, which is 1.9 years [1.6;
2.6] shorter than lowly educated women. For black men
and women, low education doubles the number of years
with cognitive impairment from 3.2 [2.1; 4.4] and 4.0 [3.0;
5.1] for medium or high education to 6.8 [5.6; 7.9] and 8.2
[7.1; 9.3] for lowly educated.
Factors that extend lifespan to older ages, like being a
woman or a non-smoker, increase the duration of cognitive
impairment. Only higher levels of education increase life in
good cognitive health while decreasing the duration of
cognitive impairment. Ironically, lifespan with cognitive
impairment is most compressed in the highly educated
smokers. Figure 2 shows the gains and losses in years lived
with cognitive impairment ﬁrst by ethnic belonging and
Table 3 Life years to live at
age 55 with or without cognitive
impairment (CI) by ethnic group
In brackets 95% conﬁdence
limits
Life expectancy Life years with CI Life years without CI
Men
All 25.13 (24.74; 25.52) 2.53 (2.32; 2.74) 22.60 (22.24; 22.96)
White 25.44 (25.04; 25.84) 1.69 (1.50; 1.89) 23.75 (23.34; 24.15)
Black 22.86 (21.86; 23.87) 5.42 (4.54; 6.30) 17.44 (16.55; 18.34)
Hispanic 27.04 (25.37; 28.70) 4.94 (3.61; 6.27) 22.10 (20.69; 23.51)
Women
All 29.43 (29.06; 29.80) 3.77 (3.52; 4.02) 25.66 (25.31; 26.01)
White 30.01 (29.59; 30.44) 2.66 (2.43; 2.89) 27.35 (26.96; 27.75)
Black 26.54 (25.64; 27.44) 6.38 (5.65; 7.12) 20.16 (19.37; 20.94)
Hispanic 31.94 (30.16; 33.72) 8.50 (6.88; 10.1) 23.44 (22.08; 24.80)
-4 -2 0 2 4 6 8
Non-Hispanic whites (REF)
Blacks
Hispanics
BMI 18.5-22.9
BMI 23-24.9 (REF)
BMI 25-29.9
BMI 30-34.9
BMI 35+
Never smoked (REF)
Stopped smoking
Currently smoking
Low education (REF)
medium education
high education
years with CI
Males Females
Fig. 2 Gains and losses in years lived with cognitive impairment (CI)
by characteristics. BMI, smoking and education show the effects for
non-Hispanic whites. Errors bars are 95% conﬁdence intervals
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effect of smoking and education. Smoking shortens life
with and without cognitive impairment. Higher education
extends life in cognitive health and compresses cognitive
impairment to a shorter period at the end of life.
A measure of interest both for individuals and public
health, is the cumulative probability of ever developing
cognitive impairment before death.
A high probability is often the prize paid for a long life.
In the HRS life table cohort of white individuals at age 55,
more than one in three women (36% [0.34%,0.38%]) will
experience cognitive impairment compared to close to one
in four men (23% [0.21%,0.24%]) (See Table 5).
Blacks face a higher cumulative probability of cognitive
impairment: respectively 44% [39%; 48%] and 53% [49%;
57%] for men and women. So do Hispanics: 46% [39%;
54%] and 61% [54%; 68%] for men and women. BMI has
little effect on the cumulative probability of cognitive
impairment, but smoking considerably lowers the life time
risk of cognitive impairment at age 55: from 28% [23%;
0.32%] and 41% [38%; 43%] for never smoking white men
and women to 18% [15%; 22%] and 22% [17%; 27%]
smokers. Smoking kills many before the onset of cognitive
impairment. High education increases life expectancy
while decreasing the probability of cognitive impairment.
The lifetime probability of cognitive impairment is lower
Table 4 Life years to live at age 55 with or without cognitive impairment (CI) by risk factor status
Life expectancy Life years with CI Life years without CI
White men
BMI 18.5–22.9 22.95 (21.82; 24.07) 1.82 (1.35; 2.28) 21.13 (20.10; 22.16)
BMI 23–24.9 25.55 (24.68; 26.43) 1.59 (1.25; 1.92) 23.97 (23.07; 24.87)
BMI 25–29.9 26.54 (25.90; 27.18) 1.73 (1.43; 2.03) 24.81 (24.19; 25.42)
BMI 30–34.9 24.93 (23.84; 26.03) 1.71 (1.01; 2.41) 23.22 (22.18; 24.27)
BMI 35? 23.02 (20.75; 25.29) 1.63 (0.06; 3.20) 21.39 (19.58; 23.21)
Never smoked 29.12 (28.23; 30.02) 2.25 (1.81; 2.70) 26.87 (26.02; 27.72)
Stopped smoking 26.16 (25.62; 26.70) 1.54 (1.35; 1.73) 24.62 (24.09; 25.16)
Currently smoking 20.34 (19.48; 21.21) 1.52 (1.09; 1.95) 18.82 (18.04; 19.60)
Low education 23.60 (22.84; 24.36) 2.65 (2.20; 3.11) 20.95 (20.22; 21.67)
Medium education 25.16 (24.58; 25.75) 1.32 (1.05; 1.59) 23.84 (23.27; 24.42)
High education 28.85 (27.90; 29.81) 1.05 (0.73; 1.36) 27.80 (26.88; 28.72)
White women
BMI 18.5–22.9 30.22 (29.49; 30.95) 2.82 (2.13; 3.51) 27.40 (26.71; 28.09)
BMI 23–24.9 30.12 (29.32; 30.92) 2.45 (2.01; 2.88) 27.68 (26.86; 28.49)
BMI 25–29.9 30.70 (29.93; 31.47) 2.82 (2.36; 3.28) 27.88 (27.20; 28.56)
BMI 30–34.9 29.87 (28.80; 30.94) 2.58 (1.93; 3.23) 27.29 (26.25; 28.33)
BMI 35? 25.90 (24.12; 27.69) 2.21 (1.30; 3.13) 23.69 (22.08; 25.30)
Never smoked 31.89 (31.37; 32.42) 3.00 (2.72; 3.29) 28.89 (28.43; 29.34)
Stopped smoking 29.61 (28.96; 30.26) 2.16 (1.85; 2.46) 27.46 (26.77; 28.14)
Currently smoking 24.90 (23.96; 25.84) 1.85 (1.34; 2.35) 23.06 (22.13; 23.98)
Low education 28.01 (27.19; 28.83) 3.78 (3.28; 4.29) 24.23 (23.48; 24.97)
Medium education 30.60 (30.06; 31.15) 2.24 (2.00; 2.48) 28.36 (27.87; 28.86)
High education 31.88 (30.88; 32.89) 1.89 (1.36; 2.42) 29.99 (29.09; 30.90)
In brackets 95% conﬁdence limits
Table 5 Cumulative probability of cognitive impairment (95%
conﬁdence bands) at age 55
Males Females
White 22.6% (20.7%; 24.5%) 35.9% (33.7%; 38.1%)
Black 43.9% (38.9%; 47.7%) 53.3% (49.0%; 56.5%)
Hispanic 46.2% (39.1%; 54.3%) 60.8% (53.6%; 68.1%)
BMI 18.5–22.9 24.2% (20.0%; 28.5%) 37.8% (34.3%; 41.4%)
BMI 23–24.9 22.5% (18.8%; 26.3%) 36.2% (31.7%; 40.6%)
BMI 25–29.9 22.2% (19.4%; 25.0%) 35.6% (32.4%; 38.8%)
BMI 30–34.9 20.6% (14.9%; 26.3%) 34.7% (28.4%; 41.1%)
BMI 35? 21.6% (10.3%; 33.0%) 28.4% (20.4%; 36.5%)
Never smoked 28.0% (23.4%; 32.5%) 40.7% (38.0%; 43.3%)
Stopped smoking 22.0% (19.9%; 24.1%) 31.8% (28.2%; 35.4%)
Currently smoking 18.4% (15.0%; 21.8%) 22.0% (17.4%; 26.6%)
Low education 29.6% (26.2%; 33.1%) 39.2% (35.7%; 42.6%)
Medium education 17.6% (14.6%; 20.7%) 35.7% (32.7%; 38.8%)
High education 19.8% (12.9%; 26.7%) 29.3% (22.4%; 36.2%)
BMI, smoking and education refer to white non-Hispanics only
400 M. Reuser et al.
123in the higher educated men and women, for whites
respectively 20% [13%; 27%] and 29% [22%; 36%])
compared to the lower educated people, respectively 30%
[26%; 33%] among men and 39% [36%; 43%] among
women.
When expressed as relative percentages of total life
expectancy, a long life goes with a relatively long duration
of cognitive impairment. White men live on average 6.7%
[5.9%; 7.4%]of their life after age 55 with cognitive
impairment; white women 8.9% [8.2%; 9.6%]. Black men
and women can expect to live 23.7% [20.3%; 27.1%] and
24.1% [21.6%; 26.5%] of their life over age 55 with cog-
nitive impairment, Hispanics 18.3% [13.9%; 22.6%] and
26.6% [22.4%; 30.8%]. Again education has a signiﬁcant
impact on this share, ranging from 11.2% [9.4%; 13.1%]
and 3.6% [2.6%; 4.7%] for respectively lowly and highly
educated white men and from 13.5% [11.8%; 15.2%] to
5.9% [4.2%; 7.7%] for lowly and highly educated white
women.
Discussion
The life table cohort of Americans aged 55 and over from
the HRS study shows that white race, male sex, smoking
and higher education shorten duration of life with cognitive
impairment. Blacks have both shorter life expectancies, and
they live more life years with cognitive impairment. His-
panics live longer with cognitive impairment. Women and
never smokers live more years with cognitive impairment
than men and smokers, simply because they live longer.
Self reported BMI had no notable effect on the duration of
cognitive impairment. High education increased total life-
span, but increased lifespan free of cognitive decline even
more, shortening life with cognitive impairment.
The life expectancy of the US population in 2003 was
24.6 and 28.1 for white men and women and 21.2 and 25.9
for black men and women at age 55 [31]. Calculated life
expectanciesoftheHRSwereslightlyhigher,indicatingthat
the studied population was slightly healthier than the source
population.WeexcludedsmallnumbersofpeoplewithBMI
under 18.5 and the HRS sample includes only non-institu-
tionalized persons at baseline, but follows these into long
term care institutions. Estimates of life years with cognitive
impairment will therefore be slightly underestimated.
Our ﬁndings of a short duration of cognitive impairment
in highly educated men and women agree with the cognitive
reserve hypothesis [32–34]. The cognitive reserve hypoth-
esis posits that a higher cognitive reserve leads to a more
plastic and adaptable brain, supporting more neuropatho-
logical and vascular damage before expressing clinical
dementia. Recently, the Epidemiological Clinicopatholog-
ical Studies in Europe (ELIPSE); conﬁrmed that longer
years in education were associated with a decreased
dementia risk but had no relationship to neurodegenerative
or vascular pathologies [35]. The ‘dose’ of education
reduced dementia risk independently of severity of pathol-
ogy. More education did not protect individuals from
developing neurodegenerative and vascular neuropathology
by the time they died but it mitigated the impact of
pathology on the clinical expression of dementia before
death [35]. The protective effect of high education among
African Americans was even stronger.
Our ﬁndings of increased incidence and duration of
cognitive impairment in ethnic minority groups, in the US
black and Hispanics, are consistent with other epidemi-
ologic studies describing higher prevalence and incidence
of dementia in racial and ethnic minorities [15–17, 36].
We identiﬁed many reasons why the observed occurrence
of dementia may appear higher in ethnic minorities than
in whites in the HRS. Culturally and educationally sen-
sitive diagnostic ascertainment methods lead to very dif-
ferent estimates of dementia prevalence in low and
middle income countries [37]. In less educated minority
populations, the MMSE (source of the TICS used in the
HRS) is less speciﬁc and yields lower scores [18, 38].
Differences in learned test-taking strategies, comfort with
testing staff, and cultural relevance of test items to the
interviewees explain some of the race differences
[39].Differences in levels of education between majority
and minority groups may not fully be accounted for by
actual stratiﬁcation in three classes [36, 38]. Finally,
prevalence of uncontrolled hypertension and diabetes,
known causes of dementia, is higher in African Ameri-
cans [17, 40–42]. A literature survey offered no infor-
mation on European ethnic minorities from Northern
Africa or Turkey.
We found little effect of BMI on the incidence of cog-
nitive impairment. However, weight loss induced by
imminent disease masks effects of increased BMI over the
life span, a suspected cause of dementia [2, 43, 44]. The
disentanglement of the relationships of BMI, weigh loss
and cognitive impairment is beyond the scope of this study.
Consistent with a long history of debate of smoking as a
risk factor for dementia [14], we found mixed results for
the relation between smoking and cognitive impairment.
However, any increased risk of cognitive impairment is
largely offset by the high mortality of smokers, shortening
life expectancy with cognitive impairment.
The HRS is a comprehensive social study, not a speciﬁc
epidemiological study that provides a clinical diagnosis of
dementia. The deﬁnition of cognitive impairment has to be
understood as a score of a screening tool, comparable to the
MMSE, which is correlated to, but not identical with
clinical diagnoses of cognitive impairment or dementia
[45]. A certain weakness of this study is the lack of detail
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dementia, high blood pressure, moderate and high alcohol
consumption, a history of diabetes and the presence of the
apolipoprotein E e4 allele. The main reason was to keep the
MSLT analysis parsimonious, focusing on few determi-
nants. We excluded alcohol use, as drinking 6 glasses or
more per day showed a protective effect on incidence of
cognitive impairment (results not shown). While moderate
alcohol use may protect against dementia, it is not plausible
that this holds for high levels of use [46, 47].
The results are to be interpreted as a period life table, a
demographic tool that reduces very many age speciﬁc
event rates to few and intuitively transparent durations.
Event rates over a period of 12 year of follow up in a
population are applied to a synthetic cohort from age 55 till
extinction. This illustrates a general problem of life cour-
ses: true cohorts running till old age yield information from
long ago, period data are recent but collapse many cohorts
of a population into one single imaginary cohort.
Cognitive impairment is a major cause of disability and
care dependence. All people fear loss of cognition and the
ability for self care nearly as much as death itself. Maybe
the most distressing results were the very large differences
for the ethnic minority populations of the USA. We found
no information on incidence and prevalence of dementia in
European migrant populations, maybe because old age is
still relatively infrequent. However, our migrant popula-
tions share many characteristics of the US black popula-
tion: a lower education, higher risks of social deprivation
and a high prevalence of diabetes [48]. Lacking any
information on the mental health of migrant elderly in
Europe, it seems safer to expect similar consequences
from similar characteristics. As our migrant populations
start aging, this is a most important research agenda.
Obesity showed little effects, smoking reduced morbidity,
but by killing early. The most promising result of this
study was that high levels of education not only extend
life and extend life in good health, but truly compress
cognitive impairment by postponing incidence of dementia
more than death. Raising education to the highest level
attainable in a society is therefore not only a millennium
goal for developing countries. The best investments in
future health remain investments in the best education
today. If we may extrapolate from the ethnic minorities of
the USA, this will hold particularly for our younger
migrant populations.
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